Addex Pharmaceuticals Ltd said that it will reduce its headcount by about 25% as part of a restructuring programme aimed at realising annual savings of about CHF 8 million (€6.6 million) and stretching its cash through the end of 2013. ---Subscribe to MedNous to access this article--- Company News
